Allo-HCT with unrelated donor tied to better outcomes in AML
(HealthDay)—Allogeneic hematopoietic cell transplantation (allo-HCT) with an unrelated donor (UD) results in better transplantation outcomes than cord blood transplantation (CBT) in acute myeloid leukemia (AML) patients ...
Jun 4, 2019
0
0